Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia. The company offers high energy, high current, and medium current implanters for various application requirements. It also provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. It sells its equipment and services to semiconductor chip manufacturers through its direct sales force. The company was founded in 1978 and is headquartered in Beverly, Massachusetts.
IPO Year: 2000
Exchange: NASDAQ
Website: axcelis.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/13/2025 | $90.00 | Neutral → Underperform | BofA Securities |
| 10/2/2025 | $105.00 | Hold → Buy | The Benchmark Company |
| 4/21/2025 | $50.00 | Buy → Neutral | B. Riley Securities |
| 2/12/2025 | Outperform → Mkt Perform | William Blair | |
| 11/8/2024 | Buy → Hold | The Benchmark Company | |
| 5/3/2024 | $130.00 | Hold → Buy | Craig Hallum |
| 12/15/2023 | Buy → Neutral | BofA Securities | |
| 9/15/2023 | $225.00 | Buy | BofA Securities |
| 8/4/2023 | $140.00 → $175.00 | Buy → Hold | Craig Hallum |
| 6/14/2023 | Buy → Hold | Needham |
Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
3 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
8-K - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)
10-K - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)
8-K - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)
425 - AXCELIS TECHNOLOGIES INC (0001113232) (Filed by)
SCHEDULE 13G - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
425 - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
8-K - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)
425 - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
8-K - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)
8-K - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)
Fastest customizable press release news feed in the world
President and CEO Russell Low will Present Keynote Speech at CS AsiaBEVERLY, Mass., March 19, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today that it will be the Diamond Sponsor for the Compound Semiconductor Asia Conference (CS Asia) 2026, held in conjunction with SEMICON China 2026 on March 24-27, 2026, at the Kerry Hotel in Pudong, Shanghai. Axcelis' President and CEO, Russell Low, PhD, will present an opening Keynote Speech at the event. Hongchen Zhao, PhD
Hexcel Corporation (NYSE:HXL) announced today that James (Jamie) Coogan has been appointed Executive Vice President and Chief Financial Officer effective May 1, 2026. He will report to Tom Gentile, Hexcel Chairman, CEO and President. Coogan succeeds Mike Lenz who has been serving as interim Chief Financial Officer. Lenz will remain for a period of time when Coogan joins the company as a Senior Advisor to assist with the transition. "Jamie brings the experience and the financial leadership that will help Hexcel build on our momentum as we enter a period of growth with rising commercial aircraft production rates and an expanding defense and space market," said Tom Gentile, Chairman, CEO and
David Ryzhik Appointed Interim Chief Financial OfficerBEVERLY, Mass., March 12, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced that David Ryzhik, Senior Vice President of Investor Relations and Corporate Strategy, has been appointed Interim Chief Financial Officer, effective March 12. James Coogan is leaving the Company to pursue a CFO opportunity at a public company in a different industry and will remain with the Company through April 24 to ensure a smooth transition. Axcelis will initiate a search process with the assistance of a leading executive search firm to identify its next CFO.
BEVERLY, Mass., Feb. 23, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today the company's plans to participate in the following upcoming investor conferences: The Susquehanna Financial Group Fifteenth Annual Technology Conference, taking place at the Lotte New York Palace Hotel on February 26th and virtually on February 27th, 2026. Axcelis management will host one-on-one and small group meetings on Thursday, February 26th with interested investors. For more infor
Q4 Highlights:Revenue of $238 millionGAAP Gross Margin of 47.0%, and Non-GAAP Gross Margin of 47.3%GAAP Operating Margin of 15.2% and Non-GAAP Operating Margin of 21.1%GAAP Diluted Earnings Per Share of $1.10, and Non-GAAP Diluted Earnings Per Share of $1.49BEVERLY, Mass., Feb. 17, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the fourth quarter and full year ended December 31, 2025. President and CEO Russell Low commented, "Axcelis exited 2025 on a strong note with fourth quarter results that exceeded our outlook. We achieve
BEVERLY, Mass., Feb. 6, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) ("Axcelis") today announced that its stockholders have voted to approve all proposals related to the Company's pending merger (the "Merger") with Veeco Instruments Inc. (NASDAQ:VECO) at its Special Meeting of Stockholders ("Special Meeting"). The final voting results of the Special Meeting will be reported in a Form 8-K filed by Axcelis with the U.S. Securities and Exchange Commission. The completion of the Merger remains subject to other customary closing conditions, including the final pend
PLAINVIEW, N.Y., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Veeco Instruments Inc. (NASDAQ:VECO) ("Veeco") today announced that its stockholders have voted to approve all proposals related to the Company's pending merger (the "Merger") with Axcelis Technologies, Inc. (NASDAQ:ACLS) ("Axcelis") at its Special Meeting of Stockholders ("Special Meeting"). The final voting results of the Special Meeting will be reported in a Form 8-K filed by Veeco with the U.S. Securities and Exchange Commission. The completion of the Merger remains subject to other customary closing conditions, including the final pending regulatory approval from the State Administration for Market Regulation of the People's Republi
Highlighting New Technologies That Advance Intelligent Semiconductor Manufacturing Solutions BEVERLY, Mass., Feb. 4, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today that it will showcase its innovative Purion™ platform of ion implanters at SEMICON Korea 2026. The event will take place February 11–13 at the COEX Center in Seoul, South Korea. SEMICON Korea will feature key technology developments shaping the next generation of semiconductor manufacturing, including AI driven process control, advanced packaging methodologies, and sustainable, high efficiency fab operations.
BEVERLY, Mass., Feb. 4, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today introduced the Purion H6™ high current ion implanter—engineered to meet the demands of next-generation semiconductor devices with unmatched purity, precision and productivity. The Purion H6 builds on the success of the well-established Purion H product line, integrating new technologies to support today's most advanced device manufacturing. This next generation system combines a high throughput be
BEVERLY, Mass., Jan. 26, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the fourth quarter and full year 2025 after market close on Tuesday, February 17, 2026. The Company will host a call to discuss the results for the fourth quarter and full year 2025 on Tuesday, February 17, 2026, at 5:00 p.m. ET. The call will be available via webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by register
Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.
BofA Securities downgraded Axcelis Tech from Neutral to Underperform and set a new price target of $90.00
The Benchmark Company upgraded Axcelis Tech from Hold to Buy and set a new price target of $105.00
B. Riley Securities downgraded Axcelis Tech from Buy to Neutral and set a new price target of $50.00
William Blair downgraded Axcelis Tech from Outperform to Mkt Perform
The Benchmark Company downgraded Axcelis Tech from Buy to Hold
Craig Hallum upgraded Axcelis Tech from Hold to Buy and set a new price target of $130.00
BofA Securities downgraded Axcelis Tech from Buy to Neutral
BofA Securities initiated coverage of Axcelis Tech with a rating of Buy and set a new price target of $225.00
Craig Hallum downgraded Axcelis Tech from Buy to Hold and set a new price target of $175.00 from $140.00 previously
Needham downgraded Axcelis Tech from Buy to Hold
Live finance-specific insights
Q4 Highlights:Revenue of $238 millionGAAP Gross Margin of 47.0%, and Non-GAAP Gross Margin of 47.3%GAAP Operating Margin of 15.2% and Non-GAAP Operating Margin of 21.1%GAAP Diluted Earnings Per Share of $1.10, and Non-GAAP Diluted Earnings Per Share of $1.49BEVERLY, Mass., Feb. 17, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the fourth quarter and full year ended December 31, 2025. President and CEO Russell Low commented, "Axcelis exited 2025 on a strong note with fourth quarter results that exceeded our outlook. We achieve
BEVERLY, Mass., Jan. 26, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the fourth quarter and full year 2025 after market close on Tuesday, February 17, 2026. The Company will host a call to discuss the results for the fourth quarter and full year 2025 on Tuesday, February 17, 2026, at 5:00 p.m. ET. The call will be available via webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by register
Q3 Highlights: Revenue of $213.6 millionGAAP Gross Margin of 41.6%, and Non-GAAP Gross Margin of 41.8%GAAP Operating Margin of 11.7% and Non-GAAP Operating Margin of 18.2%GAAP Diluted earnings per share of $0.83, and Non-GAAP Diluted earnings per share of $1.21BEVERLY, Mass., Nov. 4, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the third quarter ended September 30, 2025. President and CEO Russell Low commented, "We delivered another solid quarter, with sales and earnings both exceeding our expectations. We are also pleased
BEVERLY, Mass., Oct. 22, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the third quarter 2025 before the opening of the market on Tuesday, November 4, 2025. The Company will host a call the same day to discuss the results at 8:30 a.m. ET. The call will be available via webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by registering as a participant here:https://register-conf.media-server.c
Diversifies Portfolio with Complementary Capital Equipment Solutions and Expands Addressable Markets Supported by Secular Tailwinds Greater R&D Scale to Fuel Differentiated, Next-Generation Technologies for Customers Resilient Pro-Forma Operating Profile and Balance Sheet to Support Investment in Organic Growth Initiatives and Share Repurchase Program Expected to be Accretive to Non-GAAP Earnings Per Share Within the First Year Post Closing Will Host Joint Conference Call and Webcast Today at 8:30 AM ET BEVERLY, Mass., and PLAINVIEW, N.Y., Oct. 1, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) and Veeco Instruments Inc. (NASDAQ:VECO) today announced that they have entered in
Q2 Highlights: Revenue of $194.5 millionGAAP Gross Margin of 44.9%, and Non-GAAP Gross Margin of 45.2%GAAP Operating Margin of 14.9% and Non-GAAP Operating Margin of 17.7%GAAP Diluted earnings per share of $0.98, and Non-GAAP Diluted earnings per share of $1.13BEVERLY, Mass., Aug. 5, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the second quarter ended June 30, 2025. President and CEO Russell Low commented, "Axcelis delivered strong results in the second quarter despite the cyclical digestion period in many of our markets,
BEVERLY, Mass., July 17, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the second quarter 2025 before the opening of the market on Tuesday, August 5, 2025. The Company will host a call the same day to discuss the results at 8:30 a.m. ET. The call will be available via webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by registering as a participant here:https://register-conf.media-server.co
Q1 Highlights: Revenue of $192.6 millionGAAP Gross Margin of 46.1%, and Non-GAAP Gross Margin of 46.4%GAAP Operating Margin of 15.1% and Non-GAAP Operating Margin of 18.3%GAAP Diluted earnings per share of $0.88, and Non-GAAP Diluted earnings per share of $1.04BEVERLY, Mass., May 6, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the first quarter ended March 31, 2025. President and CEO Russell Low commented, "We executed well in the first quarter, delivering strong profitability despite a moderation in customer investments a
BEVERLY, Mass., April 17, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the first quarter 2025 before the opening of the market on Tuesday, May 6, 2025. The Company will host a call the same day to discuss the results at 8:30 a.m. ET. The call will be available via webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by registering as a participant here: https://register-conf.media-server.com/
Q4 Highlights: Revenue of $252.4 millionOperating Margin of 21.6%Diluted earnings per share of $1.54BEVERLY, Mass., Feb. 10, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the fourth quarter and full year ended December 31, 2024. For the full year 2024, the Company reported revenue of $1.02 billion, compared with $1.13 billion for the full year 2023. Systems revenue for the year was $782.6 million, compared to $883.6 million in 2023. Operating profit was $210.8 million in 2024, compared to $265.8 million in 2023. Net income
Live Leadership Updates
The Company Announces Planned Retirement of Doug Lawson, Executive Vice President of Corporate Marketing and Strategy BEVERLY, Mass., June 27, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today named David Ryzhik as Senior Vice President of Investor Relations and Corporate Strategy, assuming responsibility for the role in July 2024. The Company also announced the retirement of Doug Lawson, Executive Vice President of Corporate Marketing and Strategy. Mr. Lawson plans to retire in July 2024 and will remain as a Senior Advisor through July 2025.
BEVERLY, Mass., April 2, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today a shipment of the Company's Purion EXE™ SiC high energy implanter as well as a successful Purion H200™ SiC medium energy implanter evaluation closure at leading power device chipmakers located in Japan. The systems will be used for 150mm and 200mm production of silicon carbide power devices supporting automotive, industrial, energy, and other power intensive applications. Greg Redinbo,
SOLANA BEACH, Calif., July 15, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global therapy-enabling platform company providing navigation and delivery to the brain, is pleased to announce that Lynnette C. Fallon has been appointed to the Company's Board of Directors effective immediately. Ms. Fallon will also become a member of the Company's Audit Committee. Ms. Fallon is the Executive Vice President, HR/Legal, General Counsel and Secretary of Axcelis Technologies, Inc. (NASDAQ:ACLS), a provider of equipment and service solutions for the semiconductor manufacturing industry, with locations in eight countries. Ms. Fallon has held her current position sin
BEVERLY, Mass., Jan. 12, 2021 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today provided updated financial guidance for the fourth quarter of 2020. The Company expects revenue for the fourth quarter of 2020 to be approximately $120 million, above the $110 million prior guidance. Gross margin of approximately 43% is up from the previous gross margin guidance of 41%. As a result, the Company expects earnings per diluted share of approximately $0.32, up from the previous guidance of approximately $0.21. Cash will be greater than $200 million. Strong performance by our CS&I business contr
This live feed shows all institutional transactions in real time.
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)